📰 Kronos Bio News
Kronos Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kronos Bio. Real-time updates on events, politics, business and more.
June 13, 2024
Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) CEO Norbert W. Bischofberger acquired 1,378,901 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were acquired at an average cost of $0.88 per share, with a total value of $1,213,432.88. Following the transaction, the chief executive officer now directly […]
May 23, 2024
—KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed—
May 22, 2024
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 22, 2024 -- Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by...
May 21, 2024
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 -- Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by...
May 21, 2024
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small...
April 18, 2024
Vir Biotechnology, Inc. today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors at its upcoming annual meeting of stockholders on May 29, 2024...
February 27, 2024
SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 -- Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, today announced participation in the 44th...
February 15, 2024
Leon Sandler reflects on 18 years of helping MIT faculty make their research have real-world impact through the Deshpande Center for Technological Innovation.
February 13, 2024
Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 597,700 shares, a drop of 74.9% from the January 15th total of 2,380,000 shares. Currently, 1.6% of the shares of the stock are sold short. Based […]
January 25, 2024
Company eliminates three executive officer roles and appoints new Executive Leadership teamSAN MATEO, Calif., and CAMBRIDGE, Mass., Jan. 25, 2024 -- Kronos Bio, Inc. , a company dedicated to...